Abstract
Objective
To review the use of recombinant activated factor VII in paediatric cardiac surgery.
Design
Retrospective chart review.
Setting
Paediatric intensive care unit in a stand-alone university-affiliated children’s hospital.
Patients and participants
Cardiac surgical patients who received recombinant activated factor VII (rFVIIa, NovoSeven; NovoNordisk, Copenhagen, Denmark) between June 2002 and June 2003 at The Children’s Hospital at Westmead.
Results
Six children undergoing cardiac surgery received rFVIIa. Recombinant activated factor VII was administered if bleeding was excessive and persisted despite appropriate investigation and attention to haemostasis by surgical and medical staff. An intravenous dose of 180 µg/kg was given and repeated 2 h later. All of the six patients responded well to rFVIIa with achievement of haemostasis. No adverse events were noted.
Conclusions
Recombinant activated factor VII achieved haemostasis in six paediatric cardiac surgical patients. Good outcomes and no adverse events were noted in these children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Weiskopf RB (2002) Intraoperative use of recombinant activated coagulation factor VII. Anesthesiology 96:1287–1289
Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA (1998) Prospective, randomised trial of 2 doses of rFVIIa (Novoseven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 80:773–778
Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, Gilchrist GS, Gill JC, Glader B, Hoots WK, Kisker CT, Lusher JM, Rosenfield CG, Shapiro AD, Smith H, Taft E (1998) Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 80:912–918
Tobias JD, Groeper K, Berkenbosch JW (2003) Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. South Med J 96:12–16
Hendriks HG, van der Maaten JM, de Wolf J, Waterbolk TW, Slooff MJ, van der Meer J (2001) An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 93:287–289
Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U (1996) Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 26 (Suppl 1):159–164
Troianos CA, Sypula RW, Lucas, DM, D’Amico F, Mathie TB, Desai MB, Pasqual RT, Pellegrini RV, Newfeld ML (1999) The effect of prophylactic aminocaproic acid on bleeding, transfusions, platelet function and fibrinolysis during coronary artery bypass grafting. Anesthesiology 91:430–435
Tobias JD, Berkenbosch JW, Russo P (2003) Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. Pediatr Crit Care Med 4:49–51
Al Douri M, Shafi T, Al Khudairi D, Al Bokhari E, Black L, Akinwale N, Osman Musa M, Al Homaidhi A, Al Fagih M, Borum Andreasen R (2000) Effect of the administration of recombinant activated factor VII (rFVIIa; Novoseven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis 11 (Suppl 1):S121–S127
Peerlinck K, Vermylen J (1999) Acute myocardial infarction following administration of recombinant activated factor VII (Novoseven) in a patient with haemophilia A and inhibitor. Thromb Haemost 82:1775–1776
Guillet B, Pinganaud C, Proulle V, Dreyfus M, Lambert T (2002) Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII. Thromb Haemost 88:698–699
Chuansumrit A, Chantarojanasiri T, Isarangkura P, Teeraratkul S, Hongeng S, Hathirat P (2000) Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 11 (Suppl 1):S101–S105
Veldman A, Fischer D, Voigt B, Beyer PA, Schlosser R, Allendorf A, Kreuz W (2002) Life-threatening hemorrhage in neonates: management with recombinant activated factor VII. Intensive Care Med 28:1635–1637
Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M (1996) Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 111:1037–1046
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Egan, J.R., Lammi, A., Schell, D.N. et al. Recombinant activated factor VII in paediatric cardiac surgery. Intensive Care Med 30, 682–685 (2004). https://doi.org/10.1007/s00134-003-2108-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-003-2108-1